Read + Share
Amedeo Smart
Independent Medical Education
Song Y, Tilly H, Rai S, Zhang H, et al. Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial. Blood 2023;141:1971-1981.PMID: 36626583
Email
LinkedIn
Facebook
Twitter
Privacy Policy